Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D 2010 call letter reissued

Executive Summary

The latest version of the 2010 draft "call letter" to Medicare Part D plan sponsors maintains all the key formulary-related policy statements from the original version, including CMS objections to edits that impede beneficiary access to all approved indications of on-formulary drugs. The draft instructions for submitting bids for 2010 were originally released Jan. 8 (1"The Pink Sheet," Jan. 19, 2009, p. 13). It was withdrawn shortly thereafter by the new administration for review and reissued Jan. 23; comments on the draft are being accepted until March 6 and the final version is scheduled to be released March 30
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS050762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel